These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The heterogeneity of the anticoagulant response to heparin. Estes JW J Clin Pathol; 1972 Jan; 25(1):45-8. PubMed ID: 5015373 [TBL] [Abstract][Full Text] [Related]
3. [Mechanism of action of heparin]. Collen D; Hoylaerts M; Lijnen HR Verh K Acad Geneeskd Belg; 1986; 48(1):33-49. PubMed ID: 3739420 [No Abstract] [Full Text] [Related]
4. The fate of heparin in the body. Estes JW Curr Ther Res Clin Exp; 1975 Jul; 18(1 Pt1):45-57. PubMed ID: 808390 [No Abstract] [Full Text] [Related]
6. [Effect of low-molecular heparin on blood coagulation]. Harenberg J; de Vries JX; Weber E; Zimmermann R Dtsch Med Wochenschr; 1984 Jun; 109(24):951-4. PubMed ID: 6734448 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of heparin. II. Studies of time dependence in rats. Bjornsson TD; Levy G J Pharmacol Exp Ther; 1979 Aug; 210(2):243-6. PubMed ID: 458631 [TBL] [Abstract][Full Text] [Related]
8. [Heparin in therapeutics (author's transl)]. Capel P Rev Med Brux; 1981 Mar; 2(3):181-9. PubMed ID: 7015442 [No Abstract] [Full Text] [Related]
9. Activated coagulation time test: a convenient monitor of heparinization for dogs used in cardiovascular research. Wilkerson RD; Conran PB; Greene SL Lab Anim Sci; 1984 Feb; 34(1):62-5. PubMed ID: 6716959 [TBL] [Abstract][Full Text] [Related]
10. Heparin clearance in the newborn. McDonald MM; Jacobson LJ; Hay WW; Hathaway WE Pediatr Res; 1981 Jul; 15(7):1015-8. PubMed ID: 7254945 [TBL] [Abstract][Full Text] [Related]
11. Laboratory observations and clinical implications of monitoring the effect of heparin by bioassay. Goodman TL; Todd ME; Goldsmith EI Surg Gynecol Obstet; 1976 May; 142(5):673-85. PubMed ID: 1265607 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the sensitivity of an in vitro high frequency ultrasound device to monitor the coagulation process: study of the effects of heparin treatment in a murine model. Callé R; Rochefort GY; Desbuards N; Plag C; Antier D; Ossant F Ultrasound Med Biol; 2010 Feb; 36(2):295-305. PubMed ID: 20045589 [TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of a new one-stage clotting assay for heparin and low molecular weight heparins. Harenberg J J Mal Vasc; 1987; 12 Suppl B():68-70. PubMed ID: 2834495 [TBL] [Abstract][Full Text] [Related]
15. Molecular weight of heparin versus biologic activity. Some additional considerations. Losito R; Losito C Semin Thromb Hemost; 1985 Jan; 11(1):29-33. PubMed ID: 2579437 [No Abstract] [Full Text] [Related]
16. The effect of heparin on three whole blood activated clotting tests and thrombin time. Uden DL; Seay RE; Kriesmer PJ; Cipolle RJ; Payne NR ASAIO Trans; 1991; 37(2):88-91. PubMed ID: 1854557 [TBL] [Abstract][Full Text] [Related]
17. [Current data on heparin]. Choay J Agressologie; 1983 Nov; 24(10):491-4. PubMed ID: 6367508 [No Abstract] [Full Text] [Related]
18. Chemorheological studies of the effect of heparin on the course of coagulation. Overholser KA; Baysinger CB; Harris TR; Deveau T Thromb Haemost; 1976 Apr; 35(2):447-59. PubMed ID: 989642 [TBL] [Abstract][Full Text] [Related]
20. The influence of temperature upon the heparin and citrate clotting times. LOSNER S; VOLK BW Am J Med Sci; 1953 Jul; 226(1):60-4. PubMed ID: 13065283 [No Abstract] [Full Text] [Related] [Next] [New Search]